World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 October 2017
Main ID:  NCT02362360
Date of registration: 09/02/2015
Prospective Registration: No
Primary sponsor: Coloplast A/S
Public title: Investigation of a New 2-piece Ostomy Product in People With an Ileostomy or Colostomy
Scientific title: Investigation of a New 2-piece Ostomy Product in People With an Ileostomy or Colostomy
Date of first enrolment: February 2015
Target sample size: 52
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02362360
Study type:  Interventional
Study design:   
Phase:  N/A
Countries of recruitment
Denmark Germany Netherlands Norway
Contacts
Key inclusion & exclusion criteria

Inclusion Criteria:

- Have given written informed consent and in DK: signed a letter of authority

- Be at least 18 years of age and have full legal capacity

- Have had their ileostomy or colostomy for at least 3 months

- Able to use a baseplate size 15 to 40 mm

- Be able to handle the product themselves

- Normally experience faeces under the baseplate at least 3 times during 2 weeks

- Currently using a 2-piece flat product with mechanical coupling

- Willing to test both the Coloplast test product and the comparator product

- Willing to use an open bag size maxi during the investigation

- Willing to use Coloplast test product and comparator products without initial use of
accessories (except tube paste / belt)

- Willing to use at least 1 baseplate every 3rd day during the investigation

- Is able to use a custom cut product

- Be suitable for participating in the investigation

Exclusion Criteria:

- Are currently receiving or have within the past 2 months received radio-and/or
chemotherapy (low doses chemotherapy are allowed for other indications than cancer)

- Are currently receiving or have within the past month received topical steroid
treatment in the peristomal skin area (lotion or spray). Systemic steroid
(tablet/injection) treatment are allowed

- Are pregnant or breastfeeding

- Are participating in other interventional clinical investigations or have previously
participated in this investigation

- Use irrigation during the investigation (flush the intestines with water)

- Are currently suffering from peristomal skin problems i.e. bleeding and/or broken skin
(assessed by the investigator)

- Have a loop ostomy

- Have known hypersensitivity towards any of the products used in the investigation



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Colostomy
Ileostomy
Intervention(s)
Device: Comparator (Hollister)
Device: Coloplast Test Product
Primary Outcome(s)
Fit to the Peristomal Area, Measured by a 5-point Scale Ranging From "Very Poor" to "Very Good". [Time Frame: 21 +/- 3 days]
Secondary Outcome(s)
Secondary ID(s)
CP255
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available: Yes
Date Posted: 11/10/2016
Date Completed:
URL: https://clinicaltrials.gov/ct2/show/results/NCT02362360
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history